Interplay Between Patient Colonization and Environmental Contamination With Vancomycin-Resistant Enterococci and Their Association With Patient Health Outcomes in Postacute Care.

contamination Enterococcus health outcome nursing home postacute

Journal

Open forum infectious diseases
ISSN: 2328-8957
Titre abrégé: Open Forum Infect Dis
Pays: United States
ID NLM: 101637045

Informations de publication

Date de publication:
Jan 2020
Historique:
received: 29 08 2019
accepted: 05 12 2019
entrez: 29 1 2020
pubmed: 29 1 2020
medline: 29 1 2020
Statut: epublish

Résumé

The clinical utility of patient and environmental surveillance screening for vancomycin-resistant enterococci (VRE) in the postacute care setting has not been definitively clarified. We assessed the longitudinal relationship between patient colonization and room contamination, and we established their association with unfavorable health outcomes. Four hundred sixty-three postacute care patients were followed longitudinally from enrollment to discharge for up to 6 months. Multiple body and environmental sites were sampled at regular intervals to establish correlation between environmental contamination and patient colonization and with longer than expected stay, unplanned hospitalization, and infections adjusting for sex, age, race, Charlson's comorbidity index, and physical self-maintenance score. New VRE acquisition was more likely in patients residing in contaminated rooms (multivariable odds ratio [OR] = 3.75; 95% confidence interval [CI], 1.98-7.11) and vice versa (OR = 3.99; 95% CI, 2.16-7.51). New acquisition and new contamination were associated with increased length of stay (OR = 4.36, 95% CI = 1.86-10.2 and OR = 4.61, 95% CI = 1.92-11.0, respectively) and hospitalization (OR = 2.42, 95% CI = 1.39-4.22 and OR = 2.80, 95% CI = 1.52-5.12). New-onset infections were more common with higher VRE burdens (15% in the absence of VRE, 20% when after VRE isolation only on the patient or only in the room, and 29% after VRE isolation in both the patient and the room). Room contamination with VRE is a risk factor for patient colonization, and both are associated with future adverse health outcomes in our postacute care patients. Further research is warranted to establish whether VRE screening may contribute to better understanding of risk assessment and adverse outcome prevention in postacute care.

Sections du résumé

BACKGROUND BACKGROUND
The clinical utility of patient and environmental surveillance screening for vancomycin-resistant enterococci (VRE) in the postacute care setting has not been definitively clarified. We assessed the longitudinal relationship between patient colonization and room contamination, and we established their association with unfavorable health outcomes.
METHODS METHODS
Four hundred sixty-three postacute care patients were followed longitudinally from enrollment to discharge for up to 6 months. Multiple body and environmental sites were sampled at regular intervals to establish correlation between environmental contamination and patient colonization and with longer than expected stay, unplanned hospitalization, and infections adjusting for sex, age, race, Charlson's comorbidity index, and physical self-maintenance score.
RESULTS RESULTS
New VRE acquisition was more likely in patients residing in contaminated rooms (multivariable odds ratio [OR] = 3.75; 95% confidence interval [CI], 1.98-7.11) and vice versa (OR = 3.99; 95% CI, 2.16-7.51). New acquisition and new contamination were associated with increased length of stay (OR = 4.36, 95% CI = 1.86-10.2 and OR = 4.61, 95% CI = 1.92-11.0, respectively) and hospitalization (OR = 2.42, 95% CI = 1.39-4.22 and OR = 2.80, 95% CI = 1.52-5.12). New-onset infections were more common with higher VRE burdens (15% in the absence of VRE, 20% when after VRE isolation only on the patient or only in the room, and 29% after VRE isolation in both the patient and the room).
CONCLUSIONS CONCLUSIONS
Room contamination with VRE is a risk factor for patient colonization, and both are associated with future adverse health outcomes in our postacute care patients. Further research is warranted to establish whether VRE screening may contribute to better understanding of risk assessment and adverse outcome prevention in postacute care.

Identifiants

pubmed: 31988973
doi: 10.1093/ofid/ofz519
pii: ofz519
pmc: PMC6976341
doi:

Types de publication

Journal Article

Langues

eng

Pagination

ofz519

Subventions

Organisme : NIA NIH HHS
ID : K24 AG050685
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG024824
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG041780
Pays : United States

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America.

Références

Clin Infect Dis. 2018 Aug 31;67(6):861-868
pubmed: 29726892
Clin Infect Dis. 2018 Aug 31;67(6):837-844
pubmed: 29635360
Infect Control Hosp Epidemiol. 2015 Jul;36(7):759-66
pubmed: 25797334
Gerontologist. 1969 Autumn;9(3):179-86
pubmed: 5349366
BMC Microbiol. 2014 May 08;14:118
pubmed: 24885173
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
Infect Control Hosp Epidemiol. 2018 Oct;39(10):1178-1182
pubmed: 30178725
Infect Control Hosp Epidemiol. 2019 Jan;40(1):47-52
pubmed: 30426908
J Clin Microbiol. 2010 Nov;48(11):4156-60
pubmed: 20739498
J Hosp Infect. 2019 Jan;101(1):69-75
pubmed: 30026006
Diagn Microbiol Infect Dis. 2016 Aug;85(4):409-12
pubmed: 27312688
Indoor Air. 2015 Oct;25(5):462-74
pubmed: 25346039
Infect Control Hosp Epidemiol. 1997 Sep;18(9):622-7
pubmed: 9309433
Clin Infect Dis. 2001 Nov 15;33(10):1654-60
pubmed: 11595985
Infect Control Hosp Epidemiol. 2016 Dec;37(12):1485-1488
pubmed: 27671022
Biometrics. 1986 Mar;42(1):121-30
pubmed: 3719049
Infect Control Hosp Epidemiol. 2009 Aug;30(8):786-9
pubmed: 19591581
J Hosp Infect. 2002 Feb;50(2):110-4
pubmed: 11846537
J Am Med Dir Assoc. 2012 Jul;13(6):568.e1-13
pubmed: 22575772
Am J Infect Control. 2014 Jul;42(7):810-2
pubmed: 24792715
BMC Infect Dis. 2018 Oct 11;18(1):511
pubmed: 30309313
Lancet Infect Dis. 2008 Feb;8(2):101-13
pubmed: 17974481

Auteurs

Marco Cassone (M)

Division of Geriatrics and Palliative Care Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA.

Ziwei Zhu (Z)

University of Michigan School of Public Health, Ann Arbor, Michigan, USA.

Julia Mantey (J)

Division of Geriatrics and Palliative Care Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA.

Kristen E Gibson (KE)

Division of Geriatrics and Palliative Care Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA.

Mary B Perri (MB)

Henry Ford Health System, Detroit, Michigan, USA.

Marcus J Zervos (MJ)

Henry Ford Health System, Detroit, Michigan, USA.

Evan S Snitkin (ES)

Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, Michigan, USA.

Betsy Foxman (B)

University of Michigan School of Public Health, Ann Arbor, Michigan, USA.
Division of Geriatrics and Palliative Care Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA.

Lona Mody (L)

Division of Geriatrics and Palliative Care Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA.
Geriatric Research Education and Clinical Center, VA Ann Arbor Healthcare System, Ann Arbor, Michigan, USA.

Classifications MeSH